BCP Partnering Portal / PamGene International BV
More Information on 'PamGene International BV '
PamGene International BV - Manufacturer based in The Netherlands
About PamGene International BV
PamGene has developed new applications on her patented technology platform that measures cellular kinase activity as well as nuclear receptor activity broadly. This enables more understanding of drug interactions with these important classes of signalling molecules.
PamGene's technology is widely in use in support of drug R&D for elucidation of drug-target interactions and in support of clinical trials as a drug activity based biomarker platform, which is a paradigm shift from the more traditional biomarkers that only focus on presence of certain RNA, DNA or protein molecules and not their activity nor the interaction with the drug.
Looking for Channel Partners in:
Europe
Asia Pacific
North America
South America
Product Types:
Laboratory Equipment / Instruments
Reagents & Kits
Industries:
Products, Services & Applications:
Microarray
Molecular Biology
Proteomics
Verified Member
The BCP Partnering Portal
Where Manufacturers and Channel Partners / Distributors find each other!
- The BCP Partnering Portal is a specialized matchmaking platform featuring over 27,000 company profiles, who supply products and services within scientific fields. It serves as a crucial resource for facilitating B2B partnerships between manufacturers and channel partners.
- Developed by BioChannel Partners Ltd, an award-winning B2B partnering company with over 21 years of expertise in connecting manufacturers and channel partners of scientific products, the portal ensures that company profiles are kept up-to-date by both the BCP team and verified profile owners.
- This continuous update process ensures that users have access to accurate and current information, enhancing the platform's effectiveness in fostering successful business collaborations.
- Take advantage of this resource and join to manage your own company profile and search for new partners.